The combination of folinic acid. 5-fluorouracil. oxaliplatin and/or irinotecan (FOLFOXIRI) is the standard of care for metastatic colorectal cancer (CRC). This strategy inhibits tumor growth but provokes drug resistance and serious side effects. https://www.markymarkscott.com/product-category/pkall/